What does it really cost to bring a drug to market? For years, the standard figure has been supplied by researchers at the Tufts Center for the Study of Drug Development: $2.7 billion each, in 2017 dollars. Yet a new study looking at 10 cancer medications, among the most expensive of new drugs, has arrived at a much lower figure: a median cost of $757 million per drug. (Half cost less, and half more.)
The Health Policy Skeptic
Using evidence to improve health policy
Most Recent Posts- Mapping COVID-19 – Dartmouth Atlas of Health Care
- Is the FDA Too Conservative or Too Aggressive? – Marginal REVOLUTION
- Socioeconomic Decline and Death: Midlife Impacts of Graduating in a Recession
- The Price and Spending Impacts of Limits on Payments to Hospitals for Out-of-Network Care | RAND
- A Hard Pill to Swallow: Appreciating the Mathematical Dynamics of the Affordable Care Act – Axene Health Partners, LLC
- Mandated Sick Pay: Coverage, Utilization, and Welfare Effects
- Progressive Narrative on Homelessness Has Always Been Wrong
- Primary Care: Estimating Democratic Candidates’ Health Plans | Committee for a Responsible Federal Budget
- Affordable Hospital Care Through Competition and Price Transparency
- Reducing Administrative Costs in U.S. Health Care | The Hamilton Project
Bookmark and Share
The Health Policy Skeptic 